Atrium Therapeutics, Inc. RNA
NASDAQ · United States · Health Technology
$7.84-0.30 (-3.69%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-13 | -1.18 | -1.42 | +16.8% | $3.00M | +350.6% | +5.5%$12.17→$12.84 |
| Q1 2026 | 2026-05-14 | -0.97 | — | — | — | — | -0.5%$13.30→$13.23 |
| Q4 2025 | 2026-02-23 | -1.59 | -1.26 | -26.2% | — | — | — |
| Q3 2025 | 2025-11-10 | -1.27 | -1.10 | -15.5% | — | — | — |
| Q2 2024 | 2024-08-09 | -0.65 | -0.78 | +16.7% | — | — | — |
| Q4 2023 | 2024-02-28 | -0.79 | -0.63 | -25.4% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.